Higher resistance of Campylobacter coli compared to Campylobacter jejuni at chicken slaughterhouse

Comparative Immunology, Microbiology and Infectious Diseases
Alicia TorralboAlfonso Carbonero

Abstract

In order to compare the prevalence of Campylobacter coli and Campylobacter jejuni during the processing of broilers at slaughterhouse a total of 848 samples were analyzed during 2012 in southern Spain. Four hundred and seventy six samples were collected from cloaca, carcass surfaces and quartered carcasses. Moreover, 372 environmental swabs from equipment and scalding water were collected. Minimum inhibitory concentration (MIC) to ciprofloxacin, erythromycin, streptomycin, tetracycline and gentamicin was determined for isolates from chicken meat. The general prevalence of Campylobacter was 68.8% (40.2% of C. coli and 28.5% of C. jejuni). The relative prevalence of C. coli increased from loading dock area (41.5%) to packing area (64.6%). In contrast, the relative prevalence of C. jejuni decreased from 58.5% to 35.4%. These differences between species from initial to final area were significant (p=0.02). The highest antimicrobial resistance for C. jejuni and C. coli was detected to tetracycline (100%) and ciprofloxacin (100%), respectively. Campylobacter coli showed an antimicrobial resistance significantly higher than C. jejuni to streptomycin (p=0.002) and erythromycin (p<0.0001).

References

Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and In
May 26, 2001·Applied and Environmental Microbiology·D G NewellG Mead
Aug 2, 2001·The Journal of Antimicrobial Chemotherapy·M Van LooverenH Goossens
Nov 27, 2002·Applied and Environmental Microbiology·K L HiettS Ladely
May 7, 2003·Applied and Environmental Microbiology·Beilei GeJianghong Meng
Feb 16, 2006·International Journal of Food Microbiology·Hanne RosenquistBjarke B Christensen
May 24, 2006·Microbes and Infection·John E MooreOla Tolba
Sep 30, 2006·International Journal of Food Microbiology·V M AllenT J Humphrey
Dec 22, 2006·International Journal of Food Microbiology·Kristi Praakle-AminMarja-Liisa Hänninen
May 25, 2007·International Journal of Food Microbiology·Günter KleinEdda Bartelt
Mar 12, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Samuel K SheppardKen J Forbes
Jul 22, 2010·International Journal of Food Microbiology·Eglė KudirkienėMindaugas Malakauskas
Aug 17, 2010·Applied and Environmental Microbiology·Simone E WirzBozena M Korczak
Oct 13, 2011·Foodborne Pathogens and Disease·Tareq M OsailiRani R Al-Akhras
Oct 13, 2011·Frontiers in Microbiology·Joana SilvaPaula Teixeira

❮ Previous
Next ❯

Citations

Jul 16, 2019·Current Opinion in Infectious Diseases·Francesca SchiaffinoMargaret N Kosek
Nov 14, 2018·Antimicrobial Agents and Chemotherapy·Francesca SchiaffinoMargaret N Kosek
Feb 27, 2019·EFSA Journal·UNKNOWN European Food Safety Authority, UNKNOWN European Centre for Disease Prevention and Control
Aug 20, 2019·Applied and Environmental Microbiology·Thomai P LazouChrysostomos I Dovas
Feb 27, 2018·EFSA Journal·UNKNOWN European Food Safety Authority, UNKNOWN European Centre for Disease Prevention and Control
Feb 23, 2017·EFSA Journal·UNKNOWN European Food Safety Authority, UNKNOWN European Centre for Disease Prevention and Control

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Campylobacteriosis

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.